|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||562.83 - 562.83|
|52-week range||562.83 - 562.83|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||25.12|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Align Technology (NASDAQ:ALGN) has had a great run on the share market with its stock up by a significant 37% over the...
Align Technology (NASDAQ: ALGN) has had to deal with orthodontist office closures, competition from lower-priced competitors, and a difficult economic environment, but it turned in a stellar quarter despite the headwinds. Motley Fool contributor Brian Feroldi discusses the details for the quarter and shares how the market reacted to the latest report on an episode of Fool Live, recorded on Feb 4. Brian Feroldi: Align Technology.
In the Americas, there is increased pressure on Zimmer Biomet (ZBH) procedural volume as a result of surge in infections.